Association of the lox-1 rs1050283 polymorphism with risk for atherosclerotic cerebral infarction and its effect on slox-1 and lox-1 expression in a chinese population

Journal of Atherosclerosis and Thrombosis

Volumn 24, Issue 6, 2017, Pages 572-582

  Guo, Xin ^a   Xiang, Yuanyuan ^a   Yang, Heng ^a   Yu, Lijin ^a   Peng, Xiangdong ^a   Guo, Ren ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Atherosclerotic cerebral infarction; Lectin like oxidized LDL receptor 1; Oxidized low density lipoprotein; Rs1050283 polymorphism

Indexed keywords

CREATININE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; TRIACYLGLYCEROL; LECTIN; OLR1 PROTEIN, HUMAN; OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; BRAIN INFARCTION; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DNA POLYMORPHISM; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENOTYPING TECHNIQUE; HUMAN; HUMAN CELL; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SYSTOLIC BLOOD PRESSURE; WESTERN BLOTTING; AGED; ALLELE; ATHEROSCLEROSIS; BLOOD; CHEMISTRY; CHINA; ETHNOLOGY; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; METABOLISM; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALLELES; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; CEREBRAL INFARCTION; CHINA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LECTINS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; SCAVENGER RECEPTORS, CLASS E;

EID: 85020220413     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.36327     Document Type: Article

References (50)

1. Xu G, Ma M, Liu X, Hankey GJ: Is there a stroke belt in China and why? Stroke, 2013; 44: 1775-1783
2. Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med, 2005; 352: 1685-1695
3. Hansson GK, Libby P: The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol, 2006; 6: 508-519
4. Hansson GK: Atherosclerosis--an immune disease: The Anitschkov Lecture 2007. Atherosclerosis, 2009; 202: 2-10
5. Baeyens N, Bandyopadhyay C, Coon BG, Yun S, Schwartz MA: Endothelial fluid shear stress sensing in vascular health and disease. J Clin Invest, 2016; 126: 821-828
6. Rafieian-Kopaei M, Setorki M, Doudi M, Baradaran A, Nasri H: Atherosclerosis: process, indicators, risk factors and new hopes. Int J Prev Med, 2014; 5: 927-946
7. Lubrano V, Balzan S: LOX-1 and ROS, inseparable factors in the process of endothelial damage. Free Radic Res, 2014; 48: 841-848
8. Ding Z, Liu S, Wang X, Dai Y, Khaidakov M, Romeo F, Mehta JL: LOX-1, oxidant stress, mtDNA damage, autophagy, and immune response in atherosclerosis. Can J Physiol Pharmacol, 2014; 92: 524-530
9. Horiuchi S, Sakamoto Y, Sakai M: Scavenger receptors for oxidized and glycated proteins. Amino Acids, 2003; 25: 283-292
10. Adachi H, Tsujimoto M: Endothelial scavenger receptors. Prog Lipid Res, 2006; 45: 379-404
11. Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshi-kawa H, Aiba Y, Tanaka T, Miwa S, Katsura Y, Kita T, Masaki T: An endothelial receptor for oxidized low-density lipoprotein. Nature, 1997; 386: 73-77
12. Nagase M, Abe J, Takahashi K, Ando J, Hirose S, Fujita T: Genomic organization and regulation of expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) gene. J Biol Chem, 1998; 273: 33702-33707
13. Chen X, Zhang T, Du G: Advanced glycation end products serve as ligands for lectin-like oxidized low-density lipoprotein receptor-1(LOX-1): biochemical and binding characterizations assay. Cell Biochem Funct, 2008; 26: 760-770
14. Sawamura T, Wakabayashi I, Okamura T: LOX-1 in atherosclerotic disease. Clin Chim Acta, 2015; 440: 157-163
15. Pirillo A, Catapano AL: Soluble lectin-like oxidized low density lipoprotein receptor-1 as a biochemical marker for atherosclerosis-related diseases. Dis Markers, 2013; 35: 413-418
16. Zhao W, Ma G, Chen X: Lipopolysaccharide induced LOX-1 expression via TLR4/MyD88/ROS activated p38MAPK-NF-kappaB pathway. Vascul Pharmacol, 2014; 63: 162-172
17. Zhang Z, Zhang M, Li Y, Liu S, Ping S, Wang J, Ning F, Xie F, Li C: Simvastatin inhibits the additive activation of ERK1/2 and proliferation of rat vascular smooth muscle cells induced by combined mechanical stress and oxLDL through LOX-1 pathway. Cell Signal, 2013; 25: 332-340
18. Aramaki Y, Mitsuoka H, Toyohara M, Jinnai T, Kanatani K, Nakajima K, Mukai E, Yamada Y, Kita T, Inagaki N, Kume N: Lectin-like oxidized LDL receptor-1 (LOX-1) acts as a receptor for remnant-like lipoprotein particles (RLPs) and mediates RLP-induced migration of vascular smooth muscle cells. Atherosclerosis, 2008; 198: 272-279
19. Li L, Sawamura T, Renier G: Glucose enhances endothelial LOX-1 expression: role for LOX-1 in glucose-induced human monocyte adhesion to endothelium. Diabetes, 2003; 52: 1843-1850
20. Higuma T, Abe N, Tateyama S, Endo T, Shibutani S, Yokoyama H, Hanada K, Yamada M, Tomita H, Hanada H, Osanai T, Kume N, Okumura K: Plasma soluble lectin-like oxidized low-density lipoprotein receptor-1 as a novel prognostic biomarker in patients with ST-segment elevation acute myocardial infarction. Circ J, 2015; 79: 641-648
21. Zhang B, Chen M, Yang H, Wu T, Song C, Guo R: Evidence for involvement of the CD40/CD40L system in post-stroke epilepsy. Neurosci Lett, 2014; 567: 6-10
22. Fukui M, Tanaka M, Senmaru T, Nakanishi M, Mukai J, Ohki M, Asano M, Yamazaki M, Hasegawa G, Nakamura N: LOX-1 is a novel marker for peripheral artery disease in patients with type 2 diabetes. Metabolism, 2013; 62: 935-938
23. Zhu X, Li Z, Li C, Zhang J, Zou Z, Wang J: Ginkgo biloba extract and aspirin synergistically attenuate activated platelet-induced ROS production and LOX-1 expression in human coronary artery endothelial cells. Phytomedicine, 2013; 20: 114-119
24. Wu Z, Sawamura T, Kurdowska AK, Ji HL, Idell S, Fu J: LOX-1 deletion improves neutrophil responses, enhances bacterial clearance, and reduces lung injury in a murine polymicrobial sepsis model. Infect Immun, 2011; 79: 2865-2870
25. Khaidakov M, Wang X, Mehta JL: Potential involvement of LOX-1 in functional consequences of endothelial senescence. PLoS One, 2011; 6: e20964
26. Stancel N, Chen CC, Ke LY, Chu CS, Lu J, Sawamura T, Chen CH: Interplay between CRP, Atherogenic LDL, and LOX-1 and Its Potential Role in the Pathogenesis of Atherosclerosis. Clin Chem, 2016; 62: 320-327
27. Shaw DJ, Seese R, Ponnambalam S, Ajjan R: The role of lectin-like oxidised low-density lipoprotein receptor-1 in vascular pathology. Diab Vasc Dis Res, 2014; 11: 410-418
28. Feng Y, Cai ZR, Tang Y, Hu G, Lu J, He D, Wang S: TLR4/NF-kappaB signaling pathway-mediated and oxLDL-induced up-regulation of LOX-1, MCP-1, and VCAM-1 expressions in human umbilical vein endothelial cells. Genet Mol Res, 2014; 13: 680-695
29. Ⅱ-induced inflammation by inhibiting LOX-1 expression. Inflamm Res, 2013; 62: 219-228
30. Lin J, Xu Y, Zhao T, Sun L, Yang M, Liu T, Sun H, Zhang L: Genistein suppresses smooth muscle cell-derived foam cell formation through tyrosine kinase pathway. Biochem Biophys Res Commun, 2015; 463: 1297-1304
31. Chen X, Zhang H, Hill MA, Zhang C, Park Y: Regulation of Coronary Endothelial Function by Interactions between TNF-alpha, LOX-1 and Adiponectin in Apolipoprotein E Knockout Mice. J Vasc Res, 2016; 52: 372-382
32. Xu X, Gao X, Potter BJ, Cao JM, Zhang C: Anti-LOX-1 rescues endothelial function in coronary arterioles in atherosclerotic ApoE knockout mice. Arterioscler Thromb Vasc Biol, 2007; 27: 871-877
33. Neri SG, Coppo M, Bandinelli M, Paoletti P, Toscano T, Micalizzi E, Chiostri M, Boddi M: Exaggerated myocardial oxLDL amount and LOX-1 receptor over-expression associated with coronary microvessel inflammation in unstable angina. Atherosclerosis, 2013; 226: 476-482
34. Liu X, Zhu RX, Li L, He ZY: Association of LOX-1 gene polymorphisms with cerebral infarction in northern Chinese Han population. Lipids Health Dis, 2014; 13: 55
35. Man BL, Baum L, Fu YP, Chan YY, Lam W, Hui CF, Leung WH, Wong KS: Genetic polymorphisms of Chinese patients with ischemic stroke and concurrent steno-ses of extracranial and intracranial vessels. J Clin Neurosci, 2010; 17: 1244-1247
36. Palmieri VO, Coppola B, Grattagliano I, Casieri V, Cardi-nale G, Portincasa P, Palasciano G, Di Serio F: Oxidized LDL receptor 1 gene polymorphism in patients with metabolic syndrome. Eur J Clin Invest, 2013; 43: 41-48
37. Mango R, Clementi F, Borgiani P, Forleo GB, Federici M, Contino G, Giardina E, Garza L, Fahdi IE, Lauro R, Mehta JL, Novelli G, Romeo F: Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction. J Med Genet, 2003; 40: 933-936
38. Chen Q, Reis SE, Kammerer C, Craig WY, LaPierre SE, Zimmer EL, McNamara DM, Pauly DF, Sharaf B, Hol-ubkov R, Bairey MC, Sopko G, Bontempo F, Kamboh MI: Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) gene and the risk of coronary artery disease. Circulation, 2003; 107: 3146-3151
39. ＞T polymorphism of the oxidized LDL-receptor 1 (OLR1) gene does not associate with coronary artery disease in Italian CAD patients or with the severity of coronary disease. Nutr Metab Cardiovasc Dis, 2006; 16: 345-352
40. Novelli G, Borgiani P, Mango R, Lauro R, Romeo F: Further evidence that polymorphisms of the OLR1 gene are associated with susceptibility to coronary artery disease and myocardial infarction. Nutr Metab Cardiovasc Dis, 2007; 17: e7-e8, e9-e10
41. Morini E, Rizzacasa B, Pucci S, Polidoro C, Ferre F, Caporossi D, Helmer CM, Novelli G, Amati F: The human rs1050286 polymorphism alters LOX-1 expres- sion through modifying miR-24 binding. J Cell Mol Med, 2016; 20: 181-187
42. Hayashida K, Kume N, Murase T, Minami M, Nakagawa D, Inada T, Tanaka M, Ueda A, Kominami G, Kambara H, Kimura T, Kita T: Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome: a novel marker for early diagnosis. Circulation, 2005; 112: 812-818
43. Inoue N, Okamura T, Kokubo Y, Fujita Y, Sato Y, Nakanishi M, Yanagida K, Kakino A, Iwamoto S, Watanabe M, Ogura S, Otsui K, Matsuda H, Uchida K, Yoshimoto R, Sawamura T: LOX index, a novel predictive biochemical marker for coronary heart disease and stroke. Clin Chem, 2010; 56: 550-558
44. Yokota C, Sawamura T, Watanabe M, Kokubo Y, Fujita Y, Kakino A, Nakai M, Toyoda K, Miyamoto Y, Minematsu K: High Levels of Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Acute Stroke: An Age-and Sex-Matched Cross-Sectional Study. J Atheroscler Thromb, 2016;
45. Kume N, Mitsuoka H, Hayashida K, Tanaka M, Kominami G, Kita T: Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a sensitive and specific biomarker for acute coronary syndrome--comparison with other biomarkers. J Cardiol, 2010; 56: 159-165
46. Kobayashi N, Hata N, Kume N, Seino Y, Inami T, Yokoyama S, Shinada T, Tomita K, Kaneshige T, Mizuno K: Soluble lectin-like oxidized low-density lipoprotein receptor-1 as an early biomarker for ST elevation myocardial infarction: time-dependent comparison with other biomarkers: time-dependent comparison with other biomarkers. Circ J, 2011; 75: 1433-1439
47. Mango R, Biocca S, Del VF, Clementi F, Sangiuolo F, Amati F, Filareto A, Grelli S, Spitalieri P, Filesi I, Favalli C, Lauro R, Mehta JL, Romeo F, Novelli G: In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction. Circ Res, 2005; 97: 152-158
48. Brinkley TE, Kume N, Mitsuoka H, Brown MD, Phares DA, Ferrell RE, Kita T, Hagberg JM: Variation in the human lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1) gene is associated with plasma soluble LOX-1 levels. Exp Physiol, 2008; 93: 1085-1090
49. Serpente M, Fenoglio C, Villa C, Cortini F, Cantoni C, Ridolfi E, Clerici F, Marcone A, Benussi L, Ghidoni R, Martinelli BF, Gallone S, Cappa S, Binetti G, Franceschi M, Rainero I, Giordana MT, Mariani C, Bresolin N, Scarpini E, Galimberti D: Role of OLR1 and its regulating hsa-miR369-3p in Alzheimer’s disease: genetics and expression analysis. J Alzheimers Dis, 2011; 26: 787-793
50. Tuten A, Aydemir B, Oncul M, Kiziler AR, Acikgoz AS, Korkmaz GG, Sozer V, Uzun H: The association of lectin-like oxidized LDL receptor 1 (LOX-1) K167N and 3’UTR188CT polymorphisms with maternal plasma soluble LOX-1 levels and preeclampsia risk in Turkish population. Arch Gynecol Obstet, 2015; 291: 563-571